Association between typical electrocardiographic abnormalities and NT-proBNP elevation in a large cohort of patients with Chagas disease from endemic area☆
Introduction
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and remains a health problem despite the partial control of its transmission. The World Health Organization estimates that approximately 8 million people have been infected, particularly in Latin America where the disease is endemic. In recent decades, the epidemiological profile has changed due to migratory movements, which has led to both the urbanization and globalization of the disease. There are nearly 300,000 infected people in USA, and 30,000 to 45,000 of these individuals have an unrecognized form of Chagas cardiomyopathy (ChCM) according to the Centers for Disease Control and Prevention [1,2].
ChCM is the most harmful complication of Chagas disease. Its annual incidence among the patients with indeterminate form is 1.85 per 100 people-years [3]. Many exams, which can easily be performed on outpatients, provide valuable information about both the prognosis of ChCM and the presence of left ventricular systolic dysfunction. Serum BNP levels were described as inversely related to the left ventricular ejection fraction, with a high positive predictive value of 80% and an even higher negative predictive value of 97% to identify those patients with low left ventricular ejection fraction [4]. The BNP, or its analog, NT-proBNP, was also described as a marker of ventricular arrhythmias [5], and diastolic dysfunction [6,7], as well as an independent predictor of death [8]. Therefore, considering these results, we assumed that high BNP levels are associated with heart failure (HF) and could be considered a surrogate marker of this condition.
The electrocardiogram (ECG) is a well-studied exam and has been considered an important tool for detection and evaluation of ChCM since the first years of its description [9]. Many of its abnormalities have been described as associated with a worse prognosis in ChCM and the need of further evaluation [[10], [11], [12], [13]]. However, it is not reported how electrocardiographic alterations correlate to BNP. Because the ECG has a low cost and is a widely available exam, it can be useful in identifying those patients with a higher probability for NT-ProBNP alterations. Therefore, the present study, aims to describe the baseline electrocardiograms of a large cohort of patients with Chagas disease from a endemic area, named São Paulo-Minas Gerais Tropical Medicine Research Center cohort (SaMi-Trop Study), and to establish an association between the number of ECG alterations evaluated according to the Minnesota Code and high levels of NT-ProBNP in T. cruzi chronically infected individuals [14].
Section snippets
Study design
This report is a cross-sectional descriptive study of ECGs and serum NT-proBNP obtained from the baseline of a large cohort of patients with Chagas disease from endemic area named SaMi-Trop Study [14]. The SaMi-Trop consists of a network of collaborating scientists in the States of Minas Gerais and São Paulo and has been established to develop and conduct research projects on Chagas disease. The SaMi-Trop study is a prospective cohort begun in 2013 with at least two years of follow-up. The
Results
The clinical characteristics of the participants are listed in Table 1. Most of this population consisted of women and low-income participants. Almost 25% have used Benzonidazol to treat Chagas disease. NT-proBNP levels were suggestive of HF in 11.7% of this population.
The electrocardiographic parameters and measurements stratified by sex and by NT-proBNP levels are described in Table 2. The elevated NT-pro BNP group has a different median QRS duration, PR interval, QTc interval (Hodges), QRS,
Discussion
This cross-sectional population-based study showed that men have more frequent electrocardiographic abnormalities than women, and that these alterations occur more often in the group with high NT-proBNP levels. The presence of major ECG abnormalities increases the odds of NT-proBNP elevation, and this relation becomes stronger if more than one abnormality coexists. Those who showed any major abnormality on the electrocardiogram had a risk of 8.12 times higher to NT-proBNP elevation. This
Conclusion
The most frequent abnormalities identified in the patients who had the Chagas cardiomyopathy are in accordance to other important populational studies. Men had more major ECG abnormalities than women. Typical electrocardiographic alterations of Chagas disease are related to greater odds of NT-proBNP elevation, which is a marker of the severity of the cardiomyopathy. This association presents no major changes even if we consider other cardiovascular risk factors, gender and age.
Declarations of interest
None.
References (32)
- et al.
Chagas disease: an overview of clinical and epidemiological aspects
J Am Coll Cardiol
(2013) - et al.
Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease
Lancet
(2002) - et al.
Brain natriuretic peptide measurement in Chagas heart disease: marker of ventricular dysfunction and arrhythmia
Int J Cardiol
(2005) - et al.
The prognostic significance of electrocardiographic changes in Chagas disease
J Electrocardiol
(2012) - et al.
Value of the electrocardiographic (P wave, T wave, QRS) axis as a predictor of mortality in 14 years in a population with a high prevalence of Chagas disease from the Bambui Cohort Study of Aging
Am J Cardiol
(2018) - et al.
Natriuretic peptides
J Am Coll Cardiol
(2007) - et al.
Major electrocardiographic abnormalities according to the Minnesota Coding System among Brazilian adults (from the ELSA-Brasil Cohort Study)
Am J Cardiol
(2017) - et al.
Electrocardiographic abnormalities and left ventricular systolic function in Chagas' heart disease
Int J Cardiol
(1990) - et al.
Clinical predictors of chronic Chagasic myocarditis progression
Rev Esp Cardiol
(2005) - et al.
T-wave axis deviation as an independent predictor of mortality in chronic Chagas' disease
Am J Cardiol
(2004)
Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in Northeast Brazil
Am Heart J
Electrocardiogram and Chagas disease: a large population database of primary care patients
Glob Heart
Frequent electrocardiographic abnormalities and associated conditions in Chagas disease patients
J Electrocardiol
Association of Elevated NT-proBNP with myocardial fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA)
J Am Coll Cardiol
Diagnosis and management of Chagas disease and cardiomyopathy
Nat Rev Cardiol
Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors
Circulation
Cited by (7)
Blood DNA methylation marks discriminate Chagas cardiomyopathy disease clinical forms
2022, Frontiers in ImmunologyLeft ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients–The SaMi-Trop cohort
2021, PLoS Neglected Tropical DiseasesDeep neural network-estimated electrocardiographic age as a mortality predictor
2021, Nature CommunicationsCohort profile update: The main and new findings from the sami-trop chagas cohort
2021, Revista do Instituto de Medicina Tropical de Sao Paulo
- ☆
The SaMi-Trop cohort study is supported by The National Institutes of Health-NIH, P50 AI098461-02.
- 1
A.L.P.R. receives unrestricted grants from CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil) and FAPEMIG (Fundação de Amparo à Pesquisa de Minas Gerais, Brazil).